Doping Suspension: Facundo Bagnis Caught by Positive Test at US Open
The 35-year-old player, a finalist in Cordoba last year, has accepted a provisional suspension after a positive test at the US Open. He states he will prove his innocence.
A new doping case on the men's tour. Argentinian Facundo Bagnis, formerly ranked 55th in the world, has accepted a provisional suspension following a positive test from the first round of qualifying at the last US Open.
Hydrochlorothiazide was found in one of the samples, a diuretic medication used, among other things, to treat high blood pressure.
As Bagnis did not have a Therapeutic Use Exemption (TUE), he began a provisional suspension on October 18th.
A two-time finalist on the ATP Tour (Santiago 2021 and Cordoba 2024), the 35-year-old player reacted to this news via a statement:
"This news completely took me by surprise. I am collaborating transparently with the ITIA to clarify this matter as quickly as possible. Furthermore, I have accepted a provisional suspension in order to devote my full attention to this process and to demonstrate that I have nothing to hide.
I want to clarify that I have never knowingly taken a banned substance. That is why I feel completely innocent. The truth will eventually come out with a just outcome.
With a team of doctors, toxicologists, and lawyers working by my side, we suspect a case of cross-contamination and we are doing everything possible for the truth to be established. That is our primary goal right now."
Bagnis's last appearance was a withdrawal in the second round of the Antofagasta Challenger in early October.
Fan Week in tennis: the US Open’s revolution and Wimbledon’s tradition, a rapidly expanding phenomenon 
When qualifying becomes a show: the transformation of Opening Week in Melbourne and Paris 
From a fight for equality to a media spectacle: the history of the “Battle of the Sexes” 
The digital era of tennis: stakes and influence of social networks on players 
